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We report the first indigenous case of disseminated
histoplasmosis in Taiwan diagnosed by histopathology of
bone marrow, microbiologic morphology, and PCR assay of
the isolated fungus. This case suggests that histoplasmosis
should be 1 of the differential diagnoses of opportunistic
infections in immunocompromised patients in Taiwan.
H
istoplasma capsulatum, a dimorphic fungus that caus-
es human disease, is endemic in North and Central
America, particularly in the region of the Ohio and
Mississippi River valleys. Humans are infected by inhala-
tion of the mycelial fragments and microconidia of the
organism. After the emergence of HIV infection, histoplas-
mosis has become 1 of many troublesome opportunistic
infections among patients with AIDS. Patients receiving
immunosuppressive agents are also predisposed to H. cap-
sulatum infection (1). Although the organism is found
worldwide, cases of histoplasmosis are rarely encountered
in Taiwan; only a few, imported, cases have been reported
in this decade (2–7). We report the first indigenous case of
disseminated histoplasmosis in Taiwan.
The Case
In November 2005, a 78-year-old man with underly-
ing rheumatoid arthritis was sent to the emergency depart-
ment with generalized weakness and poor appetite of
several weeks’duration. He had received oral therapy with
prednisolone (5 mg twice per day), hydroxychloroquine
(200 mg twice per day), sulfasalazine (1,000 mg twice per
day), and methotrexate (MTX) (15 mg per week) for 4
months. The patient’s body temperature was 38.5°C, blood
pressure was 129/80 mm Hg, pulse rate was 76 beats/min,
and respiratory rate was 20 breaths/min. Physical examina-
tion disclosed mild icteric sclera and multiple ecchymoses
on the extremities.
Acomplete blood cell count showed a leukocyte count
of 6,110/µL (4% bands, 77% segmented neutrophils, 7%
lymphocytes, 6% normoblasts, and 3% myelocytes),
hemoglobin level of 11.5 g/dL, and platelet count of
3,000/µL. Biochemical testing showed total bilirubin level
of 3.89 mg/dL (normal 0–1.3 mg/dL) and alkaline phos-
phatase level of 480 U/L (60–220 U/L). Renal function,
liver enzymes, and electrolyte levels were all within nor-
mal limits. The rheumatoid factor level was 76.3 IU/mL
(normal <15 IU/mL). The erythrocyte sedimentation rate
and C-reactive protein level were 30 mm/hour (0–20
mm/hour) and 100 mg/L (0–5 mg/L), respectively. Test
results for HIV and antinuclear antibody were negative. A
chest radiograph showed bilateral interstitial micronodules
and a fibrocalcified pattern. Abdominal ultrasonography
indicated splenomegaly. The patient was admitted with the
tentative diagnosis of MTX-induced thrombocytopenia.
Bone marrow aspiration (Figure 1) and biopsy were
performed because of refractory thrombocytopenia and the
presence of young blood cells on the peripheral blood
smears. Intravenous amphotericin B (0.7 mg/kg/day) was
administered because disseminated histoplasmosis was
highly suspected because of the bone marrow findings.
Four weeks later, the fungal culture of the bone marrow
showed growth of mold (Figure 2A and B). The microor-
ganism was subsequently identified as H. capsulatum by
PCR assay (Figure 2C) (8). No H. capsulatum was cul-
tured from the patient’s peripheral blood or sputum.
The patient’s general condition improved after admin-
istration of a total dose of 1 g of intravenous amphotericin
B, and the patient was discharged and treated with oral
itraconazole, 200 mg once a day. Two weeks later, itra-
conazole therapy was suspended because impaired liver
function was found. The patient was closely monitored for
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Figure 1. A bone marrow biopsy specimen showing numerous
oval-shaped intracellular and extracellular microorganisms (A and
B). A bone marrow aspiration smear showed numerous intracellu-
lar yeastlike microorganisms (C and D). A) hematoxylin and eosin
stain, ×1,000; B) periodic acid-Schiff stain, ×1,000; C) Gram stain,
×1,000; and D) Wright stain, ×1,000.3 months, and no clinical evidence of histoplasmosis
relapse was noted.
Conclusions
Avariety of laboratory tests for diagnosis of histoplas-
mosis, including fungal culture, histopathology, serologic
tests, antigen detection, and molecular methods, have dif-
ferent sensitivities based on clinical manifestations and
host status (9). The standard for diagnosis is isolation of H.
capsulatum from culture. However, it usually requires ≈4
weeks to grow and has a low sensitivity rate (15%) in self-
limited histoplasmosis. The knobby appearance of macro-
conidia and microconidia indicated by Lactophenol Cotton
Blue Stain (Hardy Diagnostics, Santa Maria, CA, USA) of
the mold form from fungal cultures is characteristic of H.
capsulatum (Figure 2B) (10). In histopathology, histoplas-
mosis is impressive, with its numerous ovoid-shaped
microorganisms in infected tissue (Figure 1). However,
without sufficient experience, one could misidentify
Blastomyces dermatidis, Candida glabrata, Cryptococcus
neoformans,  Penicillium marneffei,  Leishmania spp.,
Pneumocystis jirovecii, or Toxoplasma gondii as H. capsu-
latum (11). Despite a characteristic form, specific DNA
probing is usually applied for faster definitive identifica-
tion (12).
In areas where histoplasmosis is not endemic, includ-
ing Taiwan, serologic tests, antigen detection reagents, and
specific DNA probes for diagnosis of histoplasmosis are
not universally available. Among serologic tests, immun-
odiffusion and complement fixation for anti–Histoplasma
antibody detection are widely applied; sensitivity rates are
95%–100% and 82%–90% for pulmonary and disseminat-
ed histoplasmosis, respectively. Some limitations occur,
including the need for 2 to 6 weeks for antibody produc-
tion after infection, impaired production of antibodies in
immunosuppressed patients, and presence of cross-reac-
tion mainly due to paracoccidioidomycosis, blastomyco-
sis, and aspergillosis (9). Antigen detection in serum and
urine is the most useful method of diagnosing histoplasmo-
sis because it provides early diagnosis before culture and
antibody production, monitors response of therapy, and
detects relapse. The sensitivity rates of antigen detected
are 25%–75% in pulmonary histoplasmosis and 82%–95%
in disseminated histoplasmosis. Cross-reactions may occur
in cases of paracoccidioidomycosis, blastomycosis,
African histoplasmosis, and P. marneffei (9).
Although the environment in Taiwan is suitable for H.
capsulatum to grow, histoplasmosis has been rarely
encountered. In a survey of histoplasmin skin tests con-
ducted in Taiwan in the 1950s, only 7 (0.19%) of 3,589
schoolchildren tested positive, and the author concluded
histoplasmosis probably does not exist in Taiwan or is very
rare (13). The first possible case of histoplasmosis in
Taiwan was reported in 1977; however, the diagnosis was
doubtful because it was based only on histopathologic
findings in a cervical lymph node biopsy specimen, with-
out definitive fungal culture or molecular identification
(2). No further cases of histoplasmosis were reported in
Taiwan until this decade, when 6 cases were reported
(3–7). The clinical characteristics of these cases are sum-
marized in the online Appendix Table (available from
www.cdc.gov/ ncidod/ EID/ 13/1/127-appT.htm). All cases
include a history of travel or residence outside Taiwan,
where the patients might have acquired the infection; fur-
thermore, most of the patients had underlying HIV infec-
tions. Diagnoses were mostly based only on histo-
pathologic or morphologic findings in fungal cultures
because the serologic tests, antigen detection reagents, and
commercial DNA probes for diagnosis of histoplasmosis
were not available in Taiwan. In contrast to these cases, our
patient had never traveled outside Taiwan and did not have
an HIV infection. To confirm the identification of H. cap-
sulatum on the basis of histopathologic and fungal form
findings (Figures 1, 2A, and 2B), we applied a specific
PCR assay as previously described (8), and the results
were definitive (Figure 2C). The fibrocalcific nodules
found on the chest radiograph imply that either 1) the
patient might have had histoplasmosis for years and it
became disseminated because of immunosuppressive
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Figure 2. A) Colony of the mold from the patient is white-brown
with a cottony appearance on Sabouraud dextrose agar. B)
Lactophenol Cotton Blue Stain (Hardy Diagnostics, Santa Maria,
CA, USA) of the isolated mold showing thick-walled and tubercu-
late macroconidia (arrowheads) and microconidia (arrows). C)
PCR assay for identification of Histoplasma capsulatum based on
the nucleotide sequence of the M antigen. PCR products included
111-bp and 279-bp fragments amplified with primers Msp1F-
Msp1R (pair 1) and Msp2F-Msp2R (pair 2), respectively, which
confirmed the identification of H. capsulatum (8). M, molecular
mass marker.therapy for rheumatoid arthritis or 2) the patient was rein-
fected with the calcified lesions that resulted from prior
histoplasmosis. The results indicate that this is the first
definitive indigenous case of disseminated histoplasmosis
in Taiwan. Nonetheless, we were unable to monitor our
patient’s response to treatment by antigen tests, as is recom-
mended (9,14), because they are not available in Taiwan.
The rarity of diagnosed histoplasmosis cases in
Taiwan could be explained in several ways. First, the diag-
nostic rate of histoplasmosis might be markedly decreased
because of the lack of serologic and antigen testing kits
and reagents, which are useful for diagnosis of self-limited
and nondisseminated histoplasmosis. Second, pulmonary
histoplasmosis might be misdiagnosed as tuberculosis,
which is prevalent in Taiwan. Third, physicians are unfa-
miliar with histoplasmosis and may consider that histo-
plasmosis is absent in Taiwan. With increasing
immunocompromised hosts resulting from immunosup-
pressive therapy and HIV infections, as well as improved
diagnostic tests, histoplasmosis might be an emergent
infectious disease in Taiwan in the future.
In summary, although an indigenous case of histoplas-
mosis had never been encountered, it should be 1 of the
differential diagnoses of opportunistic infections in
immunocompromised patients in Taiwan. The true preva-
lence of histoplasmosis in non-disease–endemic regions
might be underestimated because of the paucity of diag-
nostic tools and familiarity with histoplasmosis.
Dr Lai is an infectious disease specialist at E-Da Hospital in
Kaohsiung County, Taiwan. His research interests include clini-
cal infectious diseases, antimicrobial drugs resistance, and the
epidemiology of nosocomial pathogens.
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